- Ongoing, recruitingTherapeutic exploratory (Phase II)
A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multiple Sclerosis
This study is looking at a new medicine, BIIB091, for people with relapsing forms of multiple sclerosis (MS). It will check how safe it is and how well it works, both on its own and when given with another MS medicine called Vumerity.
For: Relapsing Forms of Multiple SclerosisGermany · Czechia · Spain - AuthorisedTherapeutic exploratory (Phase II)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated with Dupilumab.
This study is testing a new medicine, eblasakimab, for adults with moderate to severe eczema (atopic dermatitis) who have already tried a medicine called dupilumab. Researchers want to see if it helps improve their skin and is safe.
For: Atopic DermatitisPoland · Germany